au.\*:("RAZ, Itamar")
Results 1 to 25 of 151
Selection :
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 DiabetesRAZ, Itamar.Diabetes care. 2013, Vol 36, issn 0149-5992, S139-S144, SUP2Conference Paper
Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?MOSENZON, Ofri; RAZ, Itamar.Diabetes care. 2013, Vol 36, issn 0149-5992, S212-S218, SUP2Conference Paper
Early Insulinization to Prevent Diabetes ProgressionRAZ, Itamar; MOSENZON, Ofri.Diabetes care. 2013, Vol 36, issn 0149-5992, S190-S197, SUP2Conference Paper
Therapy in the Early Stage: IncretinsCERNEA, Simona; RAZ, Itamar.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S264-S271Article
Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes DrugsHIRSHBERG, Boaz; RAZ, Itamar.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S101-S106Article
Proceedings of the 4th World Congress on Controversies to Consensus in Diabetes Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. 2013, Vol 36, issn 0149-5992, 233 p., SUP2Conference Proceedings
Proceedings of the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, 287 p.Serial Issue
American Diabetes Association Indications for Statins in Diabetes: Is there evidence?ELDOR, Roy; RAZ, Itamar.Diabetes care. 2009, Vol 32, Num 3, pp 5384-5391, issn 0149-5992, 8 p., SUPConference Paper
Albuminuria : A Great Risk Marker, but an Underestimated Target in DiabetesDE ZEEUW, Dick; RAZ, Itamar.Diabetes care. 2008, Vol 31, issn 0149-5992, S190-S193, SUP2Conference Paper
The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analysesGINSBERG, Henry N.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S107-S108Article
Sibutramine on Cardiovascular OutcomeSCHEEN, André J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S114-S119Article
Childhood Metabolic Syndrome: Must we define it to deal with it?WEISS, Ram.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S171-S176Article
Safety of PPAR AgonistsHOME, Philip.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S215-S219Article
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerabilityGARBER, Alan J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S279-S284Article
Immune modulation in type i diabetes mellitus using DiaPep277 : a short review and update of recent clinical trial results : New prospects for immunotherapy at diagnosis of type 1 diabetesELDOR, Roy; KASSEM, Sameer; RAZ, Itamar et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 4, pp 316-320, issn 1520-7552, 5 p.Article
Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes : A single-center, randomized, single-blind, 5-way crossover studyCERNEA, Simona; KIDRON, Miriam; WOHLGELERNTER, Jay et al.Clinical therapeutics. 2005, Vol 27, Num 10, pp 1562-1570, issn 0149-2918, 9 p.Article
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 DiabetesBURANT, Charles F.Diabetes care. 2013, Vol 36, issn 0149-5992, S175-S179, SUP2Conference Paper
Heart in Diabetes: A Microvascular DiseaseLAAKSO, Markku.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S145-S149Article
Comparative Efficiency and Safety of Pharmacological Approaches to the Management of ObesityHAINER, Vojtech.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S349-S354Article
The Case for: Hypoglycemia Is of Cardiovascular ImportanceLALIC, Nebojsa M.Diabetes care. 2013, Vol 36, issn 0149-5992, S264-S266, SUP2Conference Paper
Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 DiabetesLEBOVITZ, Harold E.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S225-S230Article
Incretin Effects on β-Cell Function, Replication, and Mass: The human perspectiveGARBER, Alan J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S258-S263Article
Myocardial, Perivascular, and Epicardial FatIOZZO, Patricia.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S371-S379Article
Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you needBITZUR, Rafael.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S380-S382Article
Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storageRAZ, Itamar; ELDOR, Roi; CERNEA, Simona et al.Diabetes/metabolism research and reviews (Print). 2005, Vol 21, Num 1, pp 3-14, issn 1520-7552, 12 p.Article